Medical News

RSS

Dallas plastic surgeon offers Natrelle 410 silicone breast implant to select patients

Dallas plastic surgeon Dr. Fred Hackney announced today that he is now offering the Natrelle 410 highly cohesive silicone breast implant to select patients. Commonly called the "gummy bear implant" because of its texture, these implants have recently been approved by the FDA for use by qualified, board-certified plastic surgeons.

27 Jun 2013

Dassault Systèmes launches industry solution experience for pharmaceutical, biotech companies

Dassault Systèmes, the 3DEXPERIENCE Company, a world leader in 3D design, 3D Digital Mock Up and Product Lifecycle Management solutions, announced today the launch of a new industry solution experience for pharmaceutical and biotech companies, "Licensed to Cure for BioPharma."

27 Jun 2013

Tavenner outlines specifics on health exchanges, other health law issues

The Centers for Medicare & Medicaid Services chief Marilyn Tavenner discussed health exchanges, among other things, with Georgia Health News. Other news outlets detailed the exchange developments in Minnesota and Colorado.

27 Jun 2013

Michael Nissenblatt to receive St. George National Award for outstanding service to combat cancer

Regional Cancer Care Associates LLC, one of the largest oncology physician networks in the nation, is pleased to announce that Michael Nissenblatt, M.D. has been selected as one of 25 nationally recognized individuals to receive the American Cancer Society's St. George National Award for outstanding service to the community in support of the Society's mission to combat cancer.

27 Jun 2013

Researchers study possible alternative medications to treat cancer-related pain

Researchers at the Brain and Spine Institute at John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, are studying a possible alternative to side effect-ridden opioid-based medications to treat cancer-related pain.

27 Jun 2013

Researchers to use $6.3M grant to develop novel therapeutic approaches for pediatric sarcomas

Researchers at Nationwide Children's Hospital will use a $6.3 million grant to further their study of pediatric sarcomas, a rare form of the disease that affects bone or soft tissue and accounts for 11 percent of all childhood cancers.

27 Jun 2013

Electronic health records bring risks as well as benefits

When Scot Silverstein's 84-year-old mother, Betty, starting mixing up her words, he worried she was having a stroke. So he rushed her to Abington Memorial Hospital in Pennsylvania…Electronic health records are supposed to improve medical care by providing physicians quick and easy access to a patient's history, prescriptions, lab results and other vital data.

27 Jun 2013

Manage My Practice, UBM Medica US form marketing and distribution partnership

ManageMyPractice.com, a medical practice management information and resource website, announced today a unique marketing and distribution partnership with UBM Medica US.

27 Jun 2013

FX006 demonstrates pain relief in Phase 2b osteoarthritis study, Flexion reports

Flexion Therapeutics, Inc., today reported that its lead compound FX006, a novel intra-articular, sustained release steroid, demonstrated pain relief that is of both greater magnitude and longer duration than the most commonly prescribed immediate release steroid, triamcinolone acetonide, in a Phase 2b dose-ranging trial in osteoarthritis.

27 Jun 2013

Ambit Biosciences presents data from Phase 2 ACE study of quizartinib for treatment of AML

Ambit Biosciences Corporation announced today data from the Phase 2 ACE study of quizartinib (AC220), a FLT3 inhibitor, were featured in multiple presentations at the 18th Congress of the European Hematology Association in Stockholm, Sweden.

27 Jun 2013

Calif. fines Kaiser health plan $4M after mental health care delivery delays

Regulators said the Kaiser Foundation Health Plan delayed treatment -- sometimes for more than 14 days -- for patients who needed mental health care, which is a violation of the law.

27 Jun 2013

FDA grants fast track designation to Genervon Biopharmaceuticals for ALS drug GM604

In a huge victory for ALS sufferers, FDA granted Genervon Biopharmaceuticals a fast track designation for its first in class highly effective multi-target master regulator biotechnology drug GM604 for ALS. FDA said it met the necessary criteria.

27 Jun 2013

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

MorphoSys AG and Celgene Corporation today announced an agreement to jointly develop MOR202 globally and to co-promote MOR202 in Europe.

27 Jun 2013

Covered California selects Delta Dental to offer affordable dental coverage to children

Delta Dental of California announced today its selection by Covered California as one of six companies that will make affordable dental coverage available to California children up to 19 years old in the state's health exchange.

27 Jun 2013

AAHC develops online toolkit to address non-medical issues that impact health and well-being

The Association of Academic Health Centers has developed wherehealthbegins.org, an online toolkit of best practices and resources for academic health centers and their community partners to use in addressing the broad range of non-medical issues that impact health and well-being.

27 Jun 2013

BHS takes initiative to improve health and wellness of Berkshire community with CRI

Berkshire Health Systems today announced an initiative to improve the health and wellness of the Berkshire community with its new partner, the non-profit Canyon Ranch Institute.

27 Jun 2013

Sprout Pharmaceuticals resubmits flibanserin NDA for treating HSDD in pre-menopausal women

Sprout Pharmaceuticals, the Raleigh-based pharmaceutical company developing flibanserin, a treatment being evaluated for Hypoactive Sexual Desire Disorder in pre-menopausal women, confirmed today that the company has resubmitted the New Drug Application for flibanserin earlier this year and expects US Food and Drug Agency action before the end of 2013.

27 Jun 2013

Low-molecular-weight PAHs promote conditions for cancer growth

Tobacco smoke, diesel exhaust and oil combustion carry polycyclic aromatic hydrocarbons - PAHs that are known to cause cancer. But of these PAHs, the obviously dangerous high-molecular-weight PAHs like benzo[a]pyrene (BaP) have received the vast majority of research attention.

26 Jun 2013

Kiadis Pharma to receive innovation credit from AgentschapNL to conduct Phase II study for ATIR

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that it will receive an innovation credit of up to €3 million from AgentschapNL, a division of the Dutch Ministry of Economic Affairs, to support the Phase II clinical development of Kiadis Pharma's lead pipeline product, ATIR™

26 Jun 2013

University of Manchester, F2G to develop new antifungal drug for fungal infections

F2G Ltd and The University of Manchester Announce a new €6.1million project to develop new antifungal agents to treat resistant fungal infections.

26 Jun 2013

Medical News

Dallas plastic surgeon offers Natrelle 410 silicone breast implant to select patients

Dassault Systèmes launches industry solution experience for pharmaceutical, biotech companies

Tavenner outlines specifics on health exchanges, other health law issues

Michael Nissenblatt to receive St. George National Award for outstanding service to combat cancer

Researchers study possible alternative medications to treat cancer-related pain

Researchers to use $6.3M grant to develop novel therapeutic approaches for pediatric sarcomas

Electronic health records bring risks as well as benefits

Manage My Practice, UBM Medica US form marketing and distribution partnership

FX006 demonstrates pain relief in Phase 2b osteoarthritis study, Flexion reports

Ambit Biosciences presents data from Phase 2 ACE study of quizartinib for treatment of AML

Calif. fines Kaiser health plan $4M after mental health care delivery delays

FDA grants fast track designation to Genervon Biopharmaceuticals for ALS drug GM604

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

Covered California selects Delta Dental to offer affordable dental coverage to children

AAHC develops online toolkit to address non-medical issues that impact health and well-being

BHS takes initiative to improve health and wellness of Berkshire community with CRI

Sprout Pharmaceuticals resubmits flibanserin NDA for treating HSDD in pre-menopausal women

Low-molecular-weight PAHs promote conditions for cancer growth

Kiadis Pharma to receive innovation credit from AgentschapNL to conduct Phase II study for ATIR

University of Manchester, F2G to develop new antifungal drug for fungal infections

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News